(Q48299910)

10 February 2018

title

Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion. (English)

1 reference

10 February 2018

main subject

hepatic encephalopathy

1 reference

J S Bajaj

1

1 reference

10 February 2018

K Saeian

2

1 reference

10 February 2018

C M Schubert

3

1 reference

10 February 2018

R Franco

4

1 reference

10 February 2018

J Franco

5

1 reference

10 February 2018

D M Heuman

6

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 July 2011

1 reference

10 February 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

10 February 2018

volume

34

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

103-105

1 reference

10 February 2018

Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04681.X

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04681.X

Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04681.X

Ghrelin promotes slow-wave sleep in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04681.X

High prevalence of sleep disturbance in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04681.X

Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04681.X

Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04681.X

Review article: the modern management of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04681.X

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04681.X

10.1111/J.1365-2036.2011.04681.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

21631553

1 reference

10 February 2018